2025 annual financial data
Ascentage Pharma Group International 2025 Operating margin
Direct answer
Operating margin was -211.14%.
Operating income was -1,179,161,166 CNY and net income was -1,208,909,966 CNY.
Operating cash flow was -1,174,128,000 CNY.
Get free Ascentage Pharma Group International email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 558,478,193 CNY
- Operating income
- -1,179,161,166 CNY
- Net income
- -1,208,909,966 CNY
- Operating cash flow
- -1,174,128,000 CNY
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Net marginView Operating cash flow marginView all Ascentage Pharma Group International financial years